Linde India (523457) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
18 Nov, 2025Executive summary
Unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2024 were approved and published following a board meeting on 7 February 2025.
Financial highlights
Standalone revenue from operations for Q3 FY25 was ₹6,058.57 million, down from ₹7,062.43 million in Q3 FY24; nine-month revenue was ₹18,935.01 million, down from ₹21,386.01 million year-over-year.
Standalone profit for Q3 FY25 was ₹1,139.88 million, compared to ₹1,171.54 million in Q3 FY24; nine-month profit was ₹3,299.11 million, up from ₹3,220.02 million year-over-year.
Consolidated profit for Q3 FY25 was ₹1,163.20 million, compared to ₹1,200.70 million in Q3 FY24; nine-month consolidated profit was ₹3,364.33 million, up from ₹3,286.75 million year-over-year.
Basic and diluted EPS (standalone) for Q3 FY25 was ₹13.37, compared to ₹13.74 in Q3 FY24; nine-month EPS was ₹38.68, up from ₹37.76 year-over-year.
Outlook and guidance
Management regularly evaluates business and regulatory risks, including ongoing legal and regulatory proceedings, with related uncertainties around their ultimate outcomes and impact not presently ascertainable.
Latest events from Linde India
- Q3 FY26 profit after tax rose to ₹1,933.25 million amid ongoing regulatory uncertainties.523457
Q3 25/269 Feb 2026 - Q2 FY26 saw strong revenue and profit growth, but regulatory risks remain elevated.523457
Q2 25/266 Nov 2025 - Q1 FY25 saw sequential profit growth amid ongoing SEBI scrutiny of related party transactions.523457
Q1 24/251 Sep 2025 - Stable financials amid regulatory scrutiny and mandated business valuation exercise.523457
Q2 24/251 Sep 2025 - FY25 net profit rose to Rs. 4,548.45 million amid regulatory scrutiny and a 120% dividend declared.523457
Q4 24/251 Sep 2025 - Quarterly profit and revenue declined amid regulatory scrutiny and SEBI-mandated business valuation.523457
Q1 25/261 Sep 2025